Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain
Antimicrobial susceptibility to 6 antimicrobial agents, PCR-ribotyping and molecular genetics of fluoroquinolone resistance was assessed in 70 toxigenic clinical isolates of C. difficile recovered from patients attended in a hospital in southern Spain with suspected Clostridium difficile infection....
Gespeichert in:
| Veröffentlicht in: | Anaerobe 2018-12, Vol.54, p.146-150 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 150 |
|---|---|
| container_issue | |
| container_start_page | 146 |
| container_title | Anaerobe |
| container_volume | 54 |
| creator | Arca-Suárez, J. Galán-Sánchez, F. Cano-Cano, F. García-Santos, G. Rodríguez-Iglesias, M.A. |
| description | Antimicrobial susceptibility to 6 antimicrobial agents, PCR-ribotyping and molecular genetics of fluoroquinolone resistance was assessed in 70 toxigenic clinical isolates of C. difficile recovered from patients attended in a hospital in southern Spain with suspected Clostridium difficile infection. Moxifloxacin was the least active drug, mainly driven by the aminoacid substitution Thr82Ile in GyrA, while PCR-ribotype 078 was the most prevalent lineage identified and grouped several of the fluoroquinolone resistant isolates.
•Antimicrobial susceptibility and molecular typing of C. difficile are performed.•Vancomycin, linezolid and tigecycline were the most active agents.•Ribotype 078 was the most prevalent (20%), followed by ribotype 014 (17%).•A high prevalence of fluorquinolone-resistant ribotype 078 is observed.•Thr82 to Ile in GyrA was found in the majority of the resistant isolates. |
| doi_str_mv | 10.1016/j.anaerobe.2018.09.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2114690969</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1075996418301616</els_id><sourcerecordid>2114690969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-d065eaef97c356a4b21ce7fcce24f8109a896ee26175859aa140bcfb05a3362b3</originalsourceid><addsrcrecordid>eNqFUcuO1DAQtBCIfcAvrHzkkmAnsRPfWI14SStxAM6W47R3e-TYIXYQ8xt8MY5ml-ueuqSu6lZVEXLDWc0Zl--PtQkG1jhC3TA-1EzVjMkX5JIzJaqh6buXO-5FpZTsLshVSkfGOO-EeE0uWtZI3vT8kvy9DRlntOUSGk_TliwsGUf0mE_UhInO0YPdvFlpPi0Y7ml0NMc_eA8BLbUeyyhKTNGbDGlfH3xMecUJt5lO6Bxa9ECt2dKux-DAZowhFUjzA9AUt_ywC78vBsMb8soZn-Dt47wmPz99_HH4Ut19-_z1cHtX2VYOuZqYFGDAqd62QppubLiF3lkLTeeGEoMZlAQoRnsxCGUM79ho3ciEaVvZjO01eXe-u6zx1wYp6xmLe-9NgLgl3ZS0pGJKqkKVZ2rJKaUVnF5WnM160pzpvQ991E996L0PzZQufRThzeOPbZxh-i97KqAQPpwJUJz-Rlh1sgjBwoRrSUlPEZ_78Q-mCqOv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2114690969</pqid></control><display><type>article</type><title>Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain</title><source>Access via ScienceDirect (Elsevier)</source><creator>Arca-Suárez, J. ; Galán-Sánchez, F. ; Cano-Cano, F. ; García-Santos, G. ; Rodríguez-Iglesias, M.A.</creator><creatorcontrib>Arca-Suárez, J. ; Galán-Sánchez, F. ; Cano-Cano, F. ; García-Santos, G. ; Rodríguez-Iglesias, M.A.</creatorcontrib><description>Antimicrobial susceptibility to 6 antimicrobial agents, PCR-ribotyping and molecular genetics of fluoroquinolone resistance was assessed in 70 toxigenic clinical isolates of C. difficile recovered from patients attended in a hospital in southern Spain with suspected Clostridium difficile infection. Moxifloxacin was the least active drug, mainly driven by the aminoacid substitution Thr82Ile in GyrA, while PCR-ribotype 078 was the most prevalent lineage identified and grouped several of the fluoroquinolone resistant isolates.
•Antimicrobial susceptibility and molecular typing of C. difficile are performed.•Vancomycin, linezolid and tigecycline were the most active agents.•Ribotype 078 was the most prevalent (20%), followed by ribotype 014 (17%).•A high prevalence of fluorquinolone-resistant ribotype 078 is observed.•Thr82 to Ile in GyrA was found in the majority of the resistant isolates.</description><identifier>ISSN: 1075-9964</identifier><identifier>EISSN: 1095-8274</identifier><identifier>DOI: 10.1016/j.anaerobe.2018.09.006</identifier><identifier>PMID: 30261271</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Clostridium difficile ; Fluroquinolone ; Ribotype ; Ribotype 078 ; Spain</subject><ispartof>Anaerobe, 2018-12, Vol.54, p.146-150</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-d065eaef97c356a4b21ce7fcce24f8109a896ee26175859aa140bcfb05a3362b3</citedby><cites>FETCH-LOGICAL-c368t-d065eaef97c356a4b21ce7fcce24f8109a896ee26175859aa140bcfb05a3362b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anaerobe.2018.09.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30261271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arca-Suárez, J.</creatorcontrib><creatorcontrib>Galán-Sánchez, F.</creatorcontrib><creatorcontrib>Cano-Cano, F.</creatorcontrib><creatorcontrib>García-Santos, G.</creatorcontrib><creatorcontrib>Rodríguez-Iglesias, M.A.</creatorcontrib><title>Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain</title><title>Anaerobe</title><addtitle>Anaerobe</addtitle><description>Antimicrobial susceptibility to 6 antimicrobial agents, PCR-ribotyping and molecular genetics of fluoroquinolone resistance was assessed in 70 toxigenic clinical isolates of C. difficile recovered from patients attended in a hospital in southern Spain with suspected Clostridium difficile infection. Moxifloxacin was the least active drug, mainly driven by the aminoacid substitution Thr82Ile in GyrA, while PCR-ribotype 078 was the most prevalent lineage identified and grouped several of the fluoroquinolone resistant isolates.
•Antimicrobial susceptibility and molecular typing of C. difficile are performed.•Vancomycin, linezolid and tigecycline were the most active agents.•Ribotype 078 was the most prevalent (20%), followed by ribotype 014 (17%).•A high prevalence of fluorquinolone-resistant ribotype 078 is observed.•Thr82 to Ile in GyrA was found in the majority of the resistant isolates.</description><subject>Clostridium difficile</subject><subject>Fluroquinolone</subject><subject>Ribotype</subject><subject>Ribotype 078</subject><subject>Spain</subject><issn>1075-9964</issn><issn>1095-8274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFUcuO1DAQtBCIfcAvrHzkkmAnsRPfWI14SStxAM6W47R3e-TYIXYQ8xt8MY5ml-ueuqSu6lZVEXLDWc0Zl--PtQkG1jhC3TA-1EzVjMkX5JIzJaqh6buXO-5FpZTsLshVSkfGOO-EeE0uWtZI3vT8kvy9DRlntOUSGk_TliwsGUf0mE_UhInO0YPdvFlpPi0Y7ml0NMc_eA8BLbUeyyhKTNGbDGlfH3xMecUJt5lO6Bxa9ECt2dKux-DAZowhFUjzA9AUt_ywC78vBsMb8soZn-Dt47wmPz99_HH4Ut19-_z1cHtX2VYOuZqYFGDAqd62QppubLiF3lkLTeeGEoMZlAQoRnsxCGUM79ho3ciEaVvZjO01eXe-u6zx1wYp6xmLe-9NgLgl3ZS0pGJKqkKVZ2rJKaUVnF5WnM160pzpvQ991E996L0PzZQufRThzeOPbZxh-i97KqAQPpwJUJz-Rlh1sgjBwoRrSUlPEZ_78Q-mCqOv</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Arca-Suárez, J.</creator><creator>Galán-Sánchez, F.</creator><creator>Cano-Cano, F.</creator><creator>García-Santos, G.</creator><creator>Rodríguez-Iglesias, M.A.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201812</creationdate><title>Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain</title><author>Arca-Suárez, J. ; Galán-Sánchez, F. ; Cano-Cano, F. ; García-Santos, G. ; Rodríguez-Iglesias, M.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-d065eaef97c356a4b21ce7fcce24f8109a896ee26175859aa140bcfb05a3362b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Clostridium difficile</topic><topic>Fluroquinolone</topic><topic>Ribotype</topic><topic>Ribotype 078</topic><topic>Spain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arca-Suárez, J.</creatorcontrib><creatorcontrib>Galán-Sánchez, F.</creatorcontrib><creatorcontrib>Cano-Cano, F.</creatorcontrib><creatorcontrib>García-Santos, G.</creatorcontrib><creatorcontrib>Rodríguez-Iglesias, M.A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anaerobe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arca-Suárez, J.</au><au>Galán-Sánchez, F.</au><au>Cano-Cano, F.</au><au>García-Santos, G.</au><au>Rodríguez-Iglesias, M.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain</atitle><jtitle>Anaerobe</jtitle><addtitle>Anaerobe</addtitle><date>2018-12</date><risdate>2018</risdate><volume>54</volume><spage>146</spage><epage>150</epage><pages>146-150</pages><issn>1075-9964</issn><eissn>1095-8274</eissn><abstract>Antimicrobial susceptibility to 6 antimicrobial agents, PCR-ribotyping and molecular genetics of fluoroquinolone resistance was assessed in 70 toxigenic clinical isolates of C. difficile recovered from patients attended in a hospital in southern Spain with suspected Clostridium difficile infection. Moxifloxacin was the least active drug, mainly driven by the aminoacid substitution Thr82Ile in GyrA, while PCR-ribotype 078 was the most prevalent lineage identified and grouped several of the fluoroquinolone resistant isolates.
•Antimicrobial susceptibility and molecular typing of C. difficile are performed.•Vancomycin, linezolid and tigecycline were the most active agents.•Ribotype 078 was the most prevalent (20%), followed by ribotype 014 (17%).•A high prevalence of fluorquinolone-resistant ribotype 078 is observed.•Thr82 to Ile in GyrA was found in the majority of the resistant isolates.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30261271</pmid><doi>10.1016/j.anaerobe.2018.09.006</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1075-9964 |
| ispartof | Anaerobe, 2018-12, Vol.54, p.146-150 |
| issn | 1075-9964 1095-8274 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2114690969 |
| source | Access via ScienceDirect (Elsevier) |
| subjects | Clostridium difficile Fluroquinolone Ribotype Ribotype 078 Spain |
| title | Antimicrobial susceptibility and molecular typing of toxigenic clinical isolates of Clostridium difficile causing infections in the south of Spain |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T08%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antimicrobial%20susceptibility%20and%20molecular%20typing%20of%20toxigenic%20clinical%20isolates%20of%20Clostridium%20difficile%20causing%20infections%20in%20the%20south%20of%20Spain&rft.jtitle=Anaerobe&rft.au=Arca-Su%C3%A1rez,%20J.&rft.date=2018-12&rft.volume=54&rft.spage=146&rft.epage=150&rft.pages=146-150&rft.issn=1075-9964&rft.eissn=1095-8274&rft_id=info:doi/10.1016/j.anaerobe.2018.09.006&rft_dat=%3Cproquest_cross%3E2114690969%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2114690969&rft_id=info:pmid/30261271&rft_els_id=S1075996418301616&rfr_iscdi=true |